论文部分内容阅读
1994年,美国国立儿童健康和人类发展研究所NICHD[国立健康研究院(NIH)的分支机构]就妊娠期糖皮质激素的应用举办了一次会议[1]。在15个随机试验和一些大型观察的研究基础上,会议达成了共识:产前糖皮质激素的应用可以降低50%的新生儿呼吸窘迫综合征(RDS)发生率、大幅降低颅内出
In 1994, NICHD [a division of the National Institutes of Health (NIH)] at the National Institute of Child Health and Human Development held a conference on the use of gestational glucocorticoid [1]. Based on 15 randomized trials and some large-scale observational studies, the meeting reached a consensus that the use of prenatal glucocorticoids can reduce the incidence of neonatal respiratory distress syndrome (RDS) by 50% and significantly decrease intracranial